FDA approves Cochlear Nucleus Hybrid for sale in USA
Filed with ASX ·
Watch Cochlear's latest callCochlear (ASX:COH) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cochlear (ASX:COH) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
In the deck
Later from Cochlear
- COH Chris Smith Announced as Incoming CEO of Cochlear
- Decision in US patent infringement case
- Full Year Statutory Accounts and Annual Report
- Half Year Report & Accounts
- Judgment in United States Patent Infringement Lawsuit
Follow Cochlear into a list and get an email when it puts out news.
Follow Cochlear